We are live on !
Find out more
Aperio Group Portfolio holdings
AUM
$33.8B
Turnover
6.32%
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$264M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$52.4M |
| 2 |
Tesla
TSLA
|
+$42.1M |
| 3 |
Microsoft
MSFT
|
+$16.9M |
| 4 |
Walt Disney
DIS
|
+$14.5M |
| 5 |
Morgan Stanley
MS
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever NV New York Registry Shares
UN
|
+$48.8M |
| 2 |
AT&T
T
|
+$25.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$20M |
| 4 |
Amazon
AMZN
|
+$15.7M |
| 5 |
Biogen
BIIB
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.35% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1401
Abercrombie & Fitch
ANF
$6.61B
| $1.41M | ﹤0.01% |
69,434
-601
| -0.9% | -$11K |
2015 Q2
22 quarters
|
|
1402
ABM Industries
ABM
$3.15B
| $1.41M | ﹤0.01% |
37,253
+217
| +0.6% | +$8.22K |
2014 Q1
27 quarters
|
|
1403
United Natural Foods
UNFI
$2.83B
| $1.41M | ﹤0.01% |
88,195
-9,434
| -10% | -$158K |
2014 Q1
27 quarters
|
|
1404
First Financial Bankshares
FFIN
$4.32B
| $1.41M | ﹤0.01% |
38,864
-548
| -1% | -$18K |
2014 Q4
24 quarters
|
|
1405
Haemonetics
HAE
$5.39B
| $1.41M | ﹤0.01% |
11,845
+2,069
| +21% | +$223K |
2016 Q3
17 quarters
|
|
|
CXP
1406
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.4M | ﹤0.01% |
97,630
-5,769
| -6% | -$73.4K |
2016 Q4
16 quarters
|
|
1407
J&J Snack Foods
JJSF
$1.56B
| $1.4M | ﹤0.01% |
8,997
+316
| +4% | +$46.1K |
2013 Q4
28 quarters
|
|
|
PLAN
1408
DELISTED
Anaplan, Inc.
PLAN
| $1.4M | ﹤0.01% |
19,456
+8,150
| +72% | +$530K |
2020 Q2
2 quarters
|
|
|
AAWW
1409
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.39M | ﹤0.01% |
25,559
+6
| +0% | +$352 |
2014 Q2
26 quarters
|
|
1410
Allegiant Air
ALGT
$1.85B
| $1.39M | ﹤0.01% |
7,348
+142
| +2% | +$21.8K |
2014 Q1
27 quarters
|
|
1411
Alkermes
ALKS
$7.32B
| $1.39M | ﹤0.01% |
69,680
+22,304
| +47% | +$408K |
2014 Q1
27 quarters
|
|
1412
Churchill Downs
CHDN
$5.84B
| $1.39M | ﹤0.01% |
14,272
+1,034
| +8% | +$93.9K |
2018 Q1
11 quarters
|
|
|
LGF.A
1413
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.39M | ﹤0.01% |
122,117
+41,311
| +51% | +$371K |
2018 Q4
8 quarters
|
|
1414
Adient
ADNT
$1.28B
| $1.38M | ﹤0.01% |
39,777
+2,888
| +8% | +$81.4K |
2016 Q4
16 quarters
|
|
1415
Bankunited
BKU
$3.1B
| $1.38M | ﹤0.01% |
39,764
-5,801
| -13% | -$166K |
2014 Q4
24 quarters
|
|
|
AIMC
1416
DELISTED
Altra Industrial Motion Corp
AIMC
| $1.38M | ﹤0.01% |
24,907
+691
| +3% | +$34K |
2019 Q1
7 quarters
|
|
|
NTUS
1417
DELISTED
Natus Medical Inc
NTUS
| $1.38M | ﹤0.01% |
68,810
+2,408
| +4% | +$47.2K |
2020 Q3
1 quarter
|
|
|
PFPT
1418
DELISTED
Proofpoint, Inc.
PFPT
| $1.38M | ﹤0.01% |
10,112
-97
| -1% | -$10.6K |
2017 Q1
15 quarters
|
|
|
NVTA
1419
DELISTED
Invitae Corporation
NVTA
| $1.38M | ﹤0.01% |
32,968
+6,870
| +26% | +$328K |
2020 Q1
3 quarters
|
|
1420
KRONOS Worldwide
KRO
$900M
| $1.38M | ﹤0.01% |
92,240
+1,518
| +2% | +$21.4K |
2016 Q1
19 quarters
|
|
1421
Protolabs
PRLB
$2.05B
| $1.37M | ﹤0.01% |
8,956
-153
| -2% | -$21.6K |
2016 Q3
17 quarters
|
|
1422
DELISTED
Pacific Premier Bancorp
PPBI
| $1.37M | ﹤0.01% |
43,744
+2,376
| +6% | +$66K |
2018 Q3
9 quarters
|
|
1423
Wendy's
WEN
$1.19B
| $1.37M | ﹤0.01% |
62,518
-13,154
| -17% | -$300K |
2014 Q1
27 quarters
|
|
|
MRTX
1424
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.37M | ﹤0.01% |
6,218
+1,642
| +36% | +$355K |
2020 Q2
2 quarters
|
|
1425
DELISTED
TEGNA Inc
TGNA
| $1.36M | ﹤0.01% |
97,826
+4,499
| +5% | +$60.1K |
2014 Q1
27 quarters
|
|
Similar funds
LCM
Aperio Group's Q4 2020 Portfolio in Review
As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
- Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
- Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
- Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
- Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
- Aperio Group opened 104 new positions and closed 53 in Q4 2020.
- Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.